5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeAdvanced Breast Cancer; Advanced Breast Carcinoma; Hormone Receptor Positive Breast CarcinomaRecruitingPhase 22026-07-30NCT06486883
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patientssplenic marginal zone lymphomaActive, not recruitingPhase 32026-07-22NCT05735834
iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)Cognition; Functioning, Psychosocial; Neuroimaging; Quality of Lifte; Suicide, AttemptedRecruitingNot applicable2026-05-12NCT05655390
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatmentcardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiencyEnrolling by invitationNot stated2026-05-08NCT05825898
Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorderActive, not recruitingPhase 32024-11-29NCT05086939